Literature DB >> 23565948

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

D Husereau1, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, F Augustovski, A H Briggs, J Mauskopf, E Loder.   

Abstract

Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement is an attempt to consolidate and update previous health economic evaluation guidelines efforts into one current, useful reporting guidance.The primary audiences for the CHEERS statement are researchers reporting economic evaluations and the editors and peer reviewers assessing them for publication. The need for new reporting guidance was identified by a survey of medical editors. A list of possible items based on a systematic review was created. A two round, modified Delphi panel consisting of representatives from academia, clinical practice, industry, government, and the editorial community was conducted. Out of 44 candidate items, 24 items and accompanying recommendations were developed. The recommendations are contained in a user friendly, 24 item checklist. A copy of the statement, accompanying checklist, and this report can be found on the ISPOR Health Economic Evaluations Publication Guidelines Task Force website (www.ispor.org/TaskForces/EconomicPubGuidelines.asp). We hope CHEERS will lead to better reporting, and ultimately, better health decisions. To facilitate dissemination and uptake, the CHEERS statement is being co-published across 10 health economics and medical journals. We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in 5 years.
© 2013 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2013 RCOG.

Mesh:

Year:  2013        PMID: 23565948     DOI: 10.1111/1471-0528.12241

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  12 in total

1.  The economic burden of amyotrophic lateral sclerosis: a systematic review.

Authors:  K Achtert; L Kerkemeyer
Journal:  Eur J Health Econ       Date:  2021-06-18

Review 2.  Electrical stimulation with non-implanted devices for stress urinary incontinence in women.

Authors:  Fiona Stewart; Bary Berghmans; Kari Bø; Cathryn Ma Glazener
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

3.  Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan.

Authors:  Kosuke Takata; Ken-Ichi Fujita; Yutaro Kubota; Hiroo Ishida; Wataru Ichikawa; Ken Shimada; Takashi Sekikawa; Iori Taki-Takemoto; Daisuke Kamei; Shinichi Iwai; Yasutsuna Sasaki
Journal:  J Pharm Health Care Sci       Date:  2016-11-09

Review 4.  Economic evaluation of emergency obstetric care training: a systematic review.

Authors:  Aduragbemi Banke-Thomas; Megan Wilson-Jones; Barbara Madaj; Nynke van den Broek
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-04       Impact factor: 3.007

5.  The cost effectiveness of a quality improvement program to reduce maternal and fetal mortality in a regional referral hospital in Accra, Ghana.

Authors:  David M Goodman; Rohit Ramaswamy; Marc Jeuland; Emmanuel K Srofenyoh; Cyril M Engmann; Adeyemi J Olufolabi; Medge D Owen
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

6.  e-income countries from a provider's perspective: a systematic review.

Authors:  Aduragbemi Banke-Thomas; Ibukun-Oluwa Omolade Abejirinde; Francis Ifeanyi Ayomoh; Oluwasola Banke-Thomas; Ejemai Amaize Eboreime; Charles Anawo Ameh
Journal:  BMJ Glob Health       Date:  2020-06

7.  Cost of maternal health services in low and middle-income countries: protocol for a systematic review.

Authors:  Aduragbemi Banke-Thomas; Ibukun-Oluwa Omolade Abejirinde; Oluwasola Banke-Thomas; Adamu Maikano; Charles Anawo Ameh
Journal:  BMJ Open       Date:  2019-08-20       Impact factor: 2.692

8.  Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation.

Authors:  E N Bogdanova; A O Mariandyshev; G A Balantcev; P I Eliseev; E I Nikishova; A I Gaida; D Enarson; A Detjen; R Dacombe; P P J Phillips; S B Squire; E Gospodarevskaya
Journal:  PLoS One       Date:  2019-01-29       Impact factor: 3.240

9.  Cost of Utilising Maternal Health Services in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Aduragbemi Banke-Thomas; Francis Ifeanyi Ayomoh; Ibukun-Oluwa Omolade Abejirinde; Oluwasola Banke-Thomas; Ejemai Amaize Eboreime; Charles Anawo Ameh
Journal:  Int J Health Policy Manag       Date:  2021-09-01

10.  Return-to-work intervention versus usual care for sick-listed employees: health-economic investment appraisal alongside a cluster randomised trial.

Authors:  Suzanne Lokman; Danielle Volker; Moniek C Zijlstra-Vlasveld; Evelien Pm Brouwers; Brigitte Boon; Aartjan Tf Beekman; Filip Smit; Christina M Van der Feltz-Cornelis
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.